We are live on ! Find out more
LAB icon

Standard BioTools
LAB

145 hedge funds and large institutions have $719M invested in Standard BioTools in 2024 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 47 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

311,000% more call options, than puts

Call options by funds: $3.11M | Put options by funds: $1K

519% more capital invested

Capital invested by funds: $116M → $719M (+$603M)

454% more first-time investments, than exits

New positions opened: 72 | Existing positions closed: 13

262% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 13

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

69% more funds holding

Funds holding: 86 → 145 (+59)

25.84% more ownership

Funds ownership: 65.62% → 91.46% (+26%)

Holders
145
Holders Change
+59
Holders Change %
+68.6%
% of All Funds
2.09%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
72
Increased
47
Reduced
13
Closed
13
Calls
$3.11M
Puts
$1K
Net Calls
+$3.11M
Net Calls Change
+$3.08M

Top Buyers

1
CC
Casdin Capital
New York
+$147M
2
Viking Global Investors
Viking Global Investors
Connecticut
+$142M
3
AIM
ARK Investment Management
Florida
+$31.5M
4
Millennium Management
Millennium Management
New York
+$31.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$21.5M

Top Sellers

1
CP
Caligan Partners
New York
-$15.6M
2
HBWM
Hollow Brook Wealth Management
New York
-$4.14M
3
BFM
Boothbay Fund Management
New York
-$1.15M
4
Morgan Stanley
Morgan Stanley
New York
-$578K
5
HI
HBK Investments
Texas
-$333K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
51
Boothbay Fund Management
New York
$899K -$1.15M -476,196 -59%
JJ
52
Johnson & Johnson
New Jersey
$845K +$753K +311,967 New
Man Group
53
Man Group
United Kingdom
$842K +$271K +112,424 +57%
ECM
54
ExodusPoint Capital Management
New York
$825K +$561K +232,470 +323%
PAS
55
Point72 Asia (Singapore)
Singapore
$822K +$732K +303,213 New
LCM
56
Laurion Capital Management
New York
$813K – – –
CAC
57
Cowen and Company
New York
$744K +$662K +274,420 New
DCM
58
Driehaus Capital Management
Illinois
$641K +$571K +236,479 New
MFS
59
Mirabella Financial Services
United Kingdom
$584K +$520K +215,520 New
BCM
60
Bridgeway Capital Management
Texas
$575K – – –
JF
61
Jump Financial
Illinois
$574K +$341K +141,413 +201%
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$529K +$471K +195,125 New
Legal & General Group
63
Legal & General Group
United Kingdom
$522K +$465K +192,767 New
Rockefeller Capital Management
64
Rockefeller Capital Management
New York
$433K +$70.1K +29,023 +22%
CS
65
Credit Suisse
Switzerland
$425K +$378K +156,700 New
Commonwealth Equity Services
66
Commonwealth Equity Services
Massachusetts
$423K +$273K +113,277 +264%
Point72 Asset Management
67
Point72 Asset Management
Connecticut
$386K +$344K +142,300 New
Squarepoint
68
Squarepoint
New York
$360K +$233K +96,397 +265%
SAM
69
Silverback Asset Management
North Carolina
$339K – – –
JFG
70
Jefferies Financial Group
New York
$324K +$152K +63,000 +112%
BHCM
71
Brevan Howard Capital Management
Jersey
$317K +$282K +116,905 New
Charles Schwab
72
Charles Schwab
California
$302K +$194K +80,392 +258%
YIH
73
Y-Intercept (HK)
Hong Kong
$300K +$172K +71,374 +181%
UBS AM
74
UBS AM
Illinois
$282K +$251K +104,060 New
LM
75
Luminus Management
Texas
$257K +$229K +95,000 New
1 2
3
4 5

LAB Hedge Fund Activity: Q1 2024 in Review

145 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2024, worth a combined $719M — up 519% from $116M a quarter earlier.

Buyers outnumbered sellers: 72 funds opened new LAB positions and 13 closed out — a net gain of 59 holders — while 47 added to existing stakes and 13 trimmed.

The largest buyer was Casdin Capital, adding an estimated $147M. The largest seller was Caligan Partners, exiting entirely with an estimated $15.6M sold.

  • 145 institutional investors held Standard BioTools (LAB) as of Q1 2024, up from 86 in Q4 2023.
  • Funds reported $719M of Standard BioTools stock for Q1 2024, up 519% quarter-over-quarter.
  • 72 funds opened new Standard BioTools positions in Q1 2024 and 13 closed out, a net change of +59 holders.
  • The largest Standard BioTools buyer in Q1 2024 was Casdin Capital, an estimated $147M added.
  • The largest Standard BioTools seller in Q1 2024 was Caligan Partners, an estimated $15.6M sold.

Based on aggregated 13F filings for Q1 2024.